Cryoprecipitate prepared from methylene blue-treated fresh plasma [1] (multiple letters)

Transfusion

Volumn 41, Issue 1, 2001, Pages 151-152

  Hornsey, Valerie ^a   Young, David ^a   Prowse, Chris ^a   Aznar, J A ^a   Montoro, J M ^a   Cid, A R ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; METHYLENE BLUE; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; CRYOPRECIPITATE; HUMAN; INTERMETHOD COMPARISON; LETTER; PLASMA;

BLOOD COAGULATION FACTORS; FACTOR VIII; FIBRINOGEN; HUMANS; METHYLENE BLUE; PLASMA;

EID: 0035125486     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41010151.x     Document Type: Letter

References (5)

1. 1 Aznar JA, Montoro JM, Cid AR, et al. Clotting factors in cryoprecipitate and cryosupernatant prepared from MB‐treated fresh plasma (letter). Transfusion 2000 ; 40: 493.
2. 2 Hornsey VS, Krailadsiri P, MacDonald S, et al. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus‐inactivated plasma. Br J Haematol 2000 ; 109: 665– 70.
3. 3 Castro E, Barea L, Gonzalez R, Bueno JL. Quality parameters of cryoprecipitate (Cryo) from quarantine or methy‐lene blue/light treated plasma (abstract). Transfusion 1998 ; 38 (Suppl): 27S.
4. 4 Aznar JA, Molina R, Montoro JM. Factor VIII/von Willebrand factor complex in methylene blue‐treated fresh plasma. Transfusion 1999 ; 39: 748– 50.
5. 5 Lambrecht B, Mohr H, Kneuver‐Hope J, Schmitt H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991 ; 60: 207– 13.